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SpermatogenesisAbstract Introduction: Testicular sperm extraction (TESE) and intracytoplasmic sperm injection
(ICSI) became the preferable techniques for solving the problem of azoospermic men. Non-invasive
techniques are needed to predict sperm retrieval chance before TESE to avoid the psychological and
physiological problems that may be developed.
Aim: To investigate the correlation between serum, seminal and testicular leptin levels and sperm
retrieval in functional azoospermic men.
Methods: The study included 61 men classiﬁed into 4 groups; normozoospermia (NOR),
obstructive azoospermia (OA), positive non-obstructive azoospermia (NOA (+)) and negative
non-obstructive azoospermia (NOA ()). Blood FSH, LH, Prolactin, Free and Total testosterone
levels plus serum and seminal leptin levels were measured for all groups. For azoospermic groups,
TESE and testicular leptin level were applied.
Main outcome measures: Both OA and NOR groups were used as control groups. The prediction
accuracy for FSH and serum, seminal and testicular leptin was compared by receiver operating
characteristic (ROC) curve analysis.
Results: There were no signiﬁcant differences in serum leptin levels among the four groups.
Azoospermic groups showed higher seminal leptin levels than the NOR group. Seminal and Testic-
ular leptin levels of NOA () men were signiﬁcantly increased in comparison with OA and NOA
(+) men. There was a signiﬁcant negative correlation between serum leptin and total testosterone
concentrations, and a signiﬁcant positive correlation between testicular and seminal leptin
concentrations. In ROC curve; for differentiation between positive and negative NOA, areas under
Correlation between leptin content and sperm retrieval in cases of functional azoospermia 165the curve (AUC) of testicular and seminal leptin were greater than that of serum leptin. The
combination of seminal leptin with FSH gave AUC greater than that of FSH alone.
Conclusion: There is a role for leptin in spermatogenesis, and seminal leptin can be used as a
good assistant marker to increase the prediction accuracy for sperm retrieval in NOA men espe-
cially in combination with FSH.
ª 2014 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. All rights
reserved.Introduction
Azoospermia is a medical condition of males having total
absence of spermatozoa from the ejaculate. It is found in
1–3% of the male population and approximately 10% of infer-
tile males (Jarow et al., 1989). Azoospermia is classiﬁed
according to etiology into OA and NOA. Obstructive azoo-
spermia is failure of sperm transport due to the presence of
obstruction in the seminal ducts, thus spermatogenesis is nor-
mal, while NOA is failure of sperm production or maturation
by the testis, thus there is deﬁcient spermatogenesis (NOA
(+)) or absent spermatogenesis (NOA ()) (Ginsburg
and Racowsky, 2012). In early 1990s, testicular sperm
extraction (TESE) and intracytoplasmic sperm injection
(ICSI) were introduced for the treatment of OA, later
these techniques are applied on NOA (Gardner et al., 2011),
where it was reported that sperm retrieval chance for each
biopsy is 20–50% in the NOA patients (von Eckardstein
et al., 1999).
Many predictive markers that could predict the presence of
sperm in testicular tissue were proposed. It was reported that
follicular stimulating hormone (FSH) and testicular volume
constitute the best options to make such a prediction (Toulis
et al., 2010), in addition to serum Inhibin B (Inh-B) level
(Ballesca et al., 2000; Bohring et al., 2002; Bailly et al.,
2003), seminal Inh-B level (Nagata et al., 2005), serum and
seminal levels of anti-Mu¨llerian hormone (AMH), detection
of round spermatids in seminal ﬂuid (Amer et al., 2001), as
well as the testicular histopathological ﬁndings (Su et al.,
1999; Abdel Raheem et al., 2013). None of the aforementioned
markers has gained universal acceptance (Isikoglu et al., 2006;
Mostafa et al., 2007; Duvilla et al., 2008; Mitchell et al., 2010;
Toulis et al., 2010), and with regard to taking diagnostic testic-
ular biopsies, it is an invasive procedure. Therefore the search
for a better spermatogenic non-invasive marker and more
accurate method of predicting TESE outcome is still in process
(Vernaeve et al., 2002; Ma et al., 2010).
Leptin is an adipocytokine, synthesized as a 167-amino
acid hormonal protein and it is the product of the obesity
gene. Zhang et al. have reported that leptin was originally
discovered in 1994 by Jeffrey M. Friedman and colleagues.
They also reported that mature leptin is 146 amino acids in
length, with a molecular weight of approximately 16 kDa
(Zhang et al., 1994). Originally leptin was deﬁned in associa-
tion with satiety and energy balance and claimed to be an
anti-obesity factor that functioned via a feedback effect from
adipocytes to hypothalamus. In addition it was found to play
a role in the regulation of metabolism, sexual development,
angiogenesis, hematopoiesis, immunity, gastrointestinal func-
tions, sympathetic activation, and reproduction (Ziylan et al.,
2009).Previously, some studies have linked leptin and male repro-
duction; puberty, spermatogenesis, functional regulation of the
male gonadal axis, sperm maturation, sperm capacitation and
sperm motility (El-Hefnawy et al., 2000; Kiess et al., 2000;
Kratzsch et al., 2000; Glander et al., 2002; Tena-Sempere
and Barreiro, 2002; Aquila et al., 2005; Cervero et al., 2006;
Ishikawa et al., 2007; Zorn et al., 2007; Haron et al., 2009;
Nicopoulou et al., 2009). Only a handful of studies have dealt
with leptin association with azoospermia (Steinman et al.,
2001; Zorn et al., 2007; Ma et al., 2010; Gao et al., 2011). Very
few studies have focused on the use of leptin to increase the
prediction accuracy for sperm retrieval in azoospermic men;
Ma et al. (2010) studied the use of seminal leptin as a marker
to differentiate between sperm negative and sperm positive
NOA patients and Gao et al. (2011) studied the use of both
serum and seminal leptin concentrations for the differential
diagnosis of OA and NOA.
In this study we investigated the correlation between serum,
seminal and testicular levels of leptin and sperm retrieval in
functional azoospermic men.Materials and method
Patients
The research included four groups of 61 men with mean age
33.557 ± 0.626 (24–48 years). Group 1 (n= 6) was NOR,
group 2 (n= 15) was OA, group 3 (n= 11) was non-obstruc-
tive azoospermic men with positive TESE (NOA (+)) and
group 4 (n= 29) was non-obstructive azoospermic men with
negative TESE (NOA ()). Both OA and NOR groups were
used as control groups (n= 21).
Group 1 was subjected to history taking, full examination,
determination of body mass index (BMI), measurements of
blood sugar level, semen analysis, hormonal evaluation;
including FSH, LH, Prolactin, Free and Total testosterone,
and measurement of leptin level in serum and seminal plasma.
The same protocol was applied to other groups in addition to
scrotal duplex, karyotyping, TESE, measurement of leptin
level in the testicular tissue.
Patients with genetic abnormality, varicocele or any other
known cause for azoospermia, as well as patients with diabetes
or an abnormal BMI were excluded.
Ethical approval
All patients signed a consent form before proceeding with pro-
cedures. The Research Ethical Committee (REC) at the
Department of Andrology, Cairo University, Egypt has
approved this research.
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Fasting blood samples were collected by venipuncture, allowed
to clot, and then centrifuged at 2000g for 10 min at room tem-
perature for serum separation. Sera were aliquoted and stored
at 80 C until assayed.
Semen analysis and seminal plasma preparation
According to the WHO guidelines, two or three specimens
over several weeks were collected after 2–7 days of sexual
abstinence and examined. Semen specimens were obtained
and were allowed to liquify at temperature of 20–40 C. Azo-
ospermia was conﬁrmed by examination of sperm of the
centrifuged specimens. Seminal plasma was obtained by centri-
fugation at >3000g for 15 min and then aliquoted and rapidly
stored at 80 C until assayed (World Health, 2010).
Testicular sperm extraction and tissue homogenate preparation
Single or multiple testicular biopsies were taken to obtain
sperm in both NOA and OA patients. Single site biopsy was
performed ﬁrst. If positive, the procedure is terminated. If neg-
ative, microsurgical TESE is performed. Testicular tissues were
taken in a Petri dish containing 1 ml HEPES-buffered Ham’s
F10. Under sterile conditions, testicular biopsies were minced
and shredded then examined immediately under an inverted
microscope for the presence of testicular spermatozoa in the
entire Petri dish. Tissue (0.1 g) was homogenized in 1 ml
HEPES-buffered Ham’s F10. The resulting suspension was
subjected to two freeze–thaw cycles to further break the cell
membranes. After that, the homogenates were centrifuged
for 15 min at 3000g, and supernatants were aliquoted and
stored at 80 C until assaying leptin levels in them.
Hormonal assays
Serum luteinizing hormone (LH), follicular stimulating hor-
mone (FSH), prolactin (PRL) and total testosterone (TT) lev-
els were determined by the chemiluminescence method using
an automated immunoassay analyzer (Immulite analyzer)
(Siemens Healthcare Diagnostics, Inc., USA).
Free testosterone was measured by enzyme-linked immuno-
assay (ELISA) kit (CAN-fTE-260, Diagnostics Biochem
Canada Inc., 1020 Hargrieve Road, London, Ontario,
Canada, N6E 1P5).
Leptin concentrations in serum, seminal plasma and testic-
ular tissue homogenate were measured using a solid-phase
sandwich ELISA (EAI-2395, DRG Instruments GmbH,
Germany).
Statistical analysis
By using SPSS software, version 17.0 (SPSS Inc., Chicago, IL,
USA), all mean values among groups were compared by Dun-
can’s test for pairwise comparison. Pearson’s correlation coef-
ﬁcient (r) with P-value was used to determine signiﬁcant
differences between all hormones studied. Values were given
as mean ± S.E. and P< 0.05 was considered statistically
signiﬁcant.Plotting receiver operating characteristic (ROC) curves
were performed for serum, seminal and testicular leptin levels
to evaluate the ability of serum, seminal or testicular leptin dis-
criminate between positive and negative TESE of NOA men.
Binary logistic regression analysis was performed to select
the best combination of these variables in addition to FSH
for predicting testicular sperm retrieval, using the MedCalc
software version 12.2.1.0 (MedCalc Software, Mariakerke,
Belgium).Results
Results are summarized in Tables 1–4. Values were presented
as mean ± standard error (S.E.) and P< 0.05 was considered
statistically signiﬁcant.
Duncan’s multiple range test
From Table 1, Duncan’s test shows that leptin concentrations
in sera of all studied groups were comparable.
Duncan’s test revealed that there was a statistically signiﬁ-
cant difference in the seminal leptin concentrations of the two
control groups (NOR and OA), where the OA group was
29.0% higher than the NOR group. NOA (+) and NOA
() groups differed signiﬁcantly, where the NOA () group
was 15.8% higher than the NOA (+) group. There was a sta-
tistically signiﬁcant difference between the NOA () group
and the two control groups (NOR and OA), where the NOA
() group was 53.0% higher than the NOR group and was
18.6% higher than the OA group. There was a statistically sig-
niﬁcant difference between NOA (+) and NOR groups, where
the NOA (+) group was 32.1% higher than the NOR group.
But there was no statistically signiﬁcant difference between
NOA (+) and OA groups.
Table 1 also shows concentrations of leptin in the homoge-
nate of testicular tissue for three groups only; OA, NOA (+)
and NOA (), with no data for testicular leptin in NOR
men, because ethically it is forbidden to take a testicular biopsy
from normal men. Duncan’s test suggested that NOA ()
group was signiﬁcantly different from OA and NOA (+)
groups, where the NOA () group was 25.1% higher than
the OA group and also was 14.9% higher than the NOA
(+) group. No statistically signiﬁcant difference between OA
and NOA (+) groups was found.
Correlations analysis
In Table 2, correlations between the three leptin levels; serum,
seminal and testicular leptin levels, with each other, with BMI
and with concentrations of LH, FSH, PRL, total testosterone,
and free testosterone in all investigated patients are
summarized.
In all samples (n= 61), there was a highly signiﬁcant posi-
tive correlation between concentration of serum leptin and
BMI value, P< 0.01 and there was a statistically signiﬁcant
negative correlation between concentration of serum leptin
and concentration of serum total testosterone, P< 0.05. No
statistically signiﬁcant correlations were found between
concentration of serum leptin and LH, FSH, PRL, free testos-
terone, seminal leptin and testicular leptin concentrations.
Table 1 Statistical comparisons between groups by Duncan’s range test.
NOR (n= 6) OA (n= 15) NOA (+) (n= 11) NOA () (n= 29)
Age (years) 32.000 ± 1.2383 33.867 ± 1.8149 33.364 ± 0.7419 33.793 ± 0.8715
(29–37)a (24–48)a (30–36)a (25–45)a
Glucose (mg/dl) 95.667 ± 3.3233 99.333 ± 2.8329 92.818 ± 4.3271 93.069 ± 2.0985
(86–107)a (73–110)a (60–110)a (70–110)a
BMI (kg/m2) 22.917 ± 1.0173 24.847 ± 0.7485 24.518 ± 0.6169 25.759 ± 0.4789
(18.7–25.6)a (20.2–29.4)ab (20.2–27.5)ab (18.6–29)b
LH (mIU/ml) 6.083 ± 1.3398 5.059 ± 0.8726 10.918 ± 1.4401 7.123 ± 1.0208
(1.6–11.6)a (0.19–12.2)a (5.5–20.2)b (0.37–23.4)ab
FSH (mIU/ml) 4.85 ± 1.7068 3.848 ± 0.6685 31.127 ± 5.9426 13.657 ± 1.7598
(1.7–13.2)ab (0.18–10.9)a (14.3–80)c (0.75–47.7)b
PRL (ng/ml) 6.117 ± 0.8228 16.793 ± 3.3755 25.941 ± 10.9942 17.252 ± 2.0372
(3.7–8.9)a (4.7–51)ab (4.5–130)b (5.7–50)ab
Total testosterone (nmol/l) 13.217 ± 2.5268 15.640 ± 1.7531 13.918 ± 1.9804 11.203 ± 1.3677
(5.7–21.2)a (6.3–26.2)a (5.5–24.2)a (1.1–35.1)a
Free testosterone (pmol/l) 29.683 ± 1.8895 29.680 ± 3.5173 28.936 ± 1.7858 35.324 ± 3.9465
(24–36)a (13–53.1)a (17.5–38)a (6–103.1)a
Serum leptin (ng/ml) 2.829 ± 0.6691 3.861 ± 0.6547 3.819 ± 0.7441 4.605 ± 0.4261
(0.965–5.506)a (1.398–8.958)a (1.143–8.221)a (0.784–9.058)a
Seminal leptin (ng/ml) 0.813 ± 0.0497 1.049 ± 0.0294 1.074 ± 0.0430 1.244 ± 0.0434
(0.659–0.947)a (0.714–1.183)b (0.842–1.268)b (0.473–1.716)c
Testicular leptin (ng/ml) No samples 1.353 ± 0.0378 1.473 ± 0.0529 1.692 ± 0.0392
(0.921–1.564)a (1.217–1.81)a (1.253–2.115)b
In the row, mean values marked with the same superscript letters are similar (insigniﬁcant, P> 0.05) whereas different superscripts denote
signiﬁcance (P< 0.05).
Table 2 Correlations between serum, seminal and testicular leptin with each other and with LH, FSH, PRL, total testosterone and
free testosterone concentrations in all patients investigated (n= 61).
BMI LH FSH PRL Total testo. Free testo. Serum leptin Seminal leptin Testicular Leptin
Serum leptin r +0.709** 0.045 +0.014 0.105 0.305* 0.036 +1 +0.150 +0.200
P-value 0.000 0.729 0.913 0.420 0.017 0.784 0.249 0.143
Seminal leptin r 0.128 0.005 +0.112 +0.168 0.114 +0.322* +0.150 +1 +0.486**
P-value 0.327 0.968 0.389 0.196 0.382 0.011 0.249 0.000
Testicular leptin r 0.009 +0.186 +0.094 0.105 0.242 +0.154 +0.200 +0.486** +1
P-value 0.946 0.175 0.497 0.444 0.075 0.262 0.143 0.000
* Correlation is signiﬁcant at the 0.05 level (2-tailed).
** Correlation is signiﬁcant at the 0.01 level (2-tailed).
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statistically signiﬁcant positive correlations between concentra-
tion of seminal leptin and both concentrations of serum free
testosterone and testicular leptin, P< 0.05 and P< 0.0001
respectively. No statistically signiﬁcant correlations were found
between the concentration of the seminal leptin and BMI and
concentrations of LH, FSH, PRL, total testosterone and serum
leptin.
Finally, concerning leptin of the testicular tissue, there
was a highly signiﬁcant positive correlation between con-
centration of testicular leptin and concentration of semi-
nal leptin, P< 0.0001. No statistically signiﬁcant
correlations were found between the concentration of
the testicular leptin and BMI and also concentrationsof LH, FSH, PRL, total testosterone, free testosterone
and serum leptin.
Receiver operating characteristic (ROC) and binary logistic
regression analyses
Receiver operating characteristic (ROC) curves were used to
analyze the diagnostic accuracy of serum, seminal and testicu-
lar leptin to discriminate between successful and failed TESE
in NOA patients and also to determine their best threshold
concentrations for discrimination (Table 3 and Fig. 1). Binary
logistic regression analysis was performed to select the best
combination of these variables in addition to FSH for predict-
ing testicular sperm retrieval (Table 4).
Table 3 Analysis of receiver operating characteristic curves for serum leptin, seminal leptin, and testicular leptin levels for non-
obstructive azoospermia.
AUC S.E. 95% CI Sensitivity Speciﬁcity Criterion P-value
FSH 0.828 0.0685 0.675–0.928 100 58.6 >13.3 <0.0001
Testicular leptin 0.809 0.0799 0.654–0.916 81.8 79.3 61.567 0.0001
Seminal leptin 0.773 0.0752 0.613–0.890 90.0 65.5 61.194 0.0003
Serum leptin 0.605 0.110 0.438–0.756 72.73 62.07 63.674 0.3397
AUC: Area under curve.
CI: Conﬁdence interval.
S.E.: Standard error of mean.
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curve (AUC) was the highest for FSH followed by that of tes-
ticular leptin, that of seminal leptin and ﬁnally that of serum
leptin; 0.828, 0.809, 0.773 and 0.605 respectively. This indicates
that FSH is the best in discrimination between positive and
negative TESE followed by testicular leptin, seminal leptin
then ﬁnally serum leptin. The best FSH and testicular, seminal
and serum leptin discriminative concentrations were >13.3
mIU/ml (sensitivity 100%, speciﬁcity 58.6%), 61.567 ng/ml
(sensitivity 81.8%, speciﬁcity 79.3%), 61.194 ng/ml (sensitiv-
ity 90.0%, speciﬁcity 65.5%) and 63.674 ng/ml (sensitivity
72.73%, speciﬁcity 62.07%) respectively.
Data from Table 4 summarizes values of AUC for combined
variables which were the highest for combination of the four
predicting variables with 0.909 AUC value, then combination
of FSH, testicular leptin and seminal leptin with 0.897 AUC
value, then combination of FSH and testicular leptin and com-
bination of FSH, serum leptin and testicular leptin with the
same AUC value; 0.893, then combination of FSH and seminal
leptin with 0.887 AUC value, then combination of FSH, serum
leptin and seminal leptin with 0.881 AUC value, then FSH with
0.828 AUC value, then combination of seminal leptin and tes-
ticular leptin and combination of serum leptin, seminal leptin
and testicular leptin with the same AUC value; 0.824, then
combination of FSH and serum leptin with 0.821 AUC value,Table 4 Analysis of binary regression for FSH, serum leptin, s
azoospermia.
FSH+ serum leptin + seminal leptin + testicular leptin
FSH+ seminal leptin + testicular leptin
FSH+ testicular leptin
FSH+ serum leptin + testicular leptin
FSH+ seminal leptin
FSH+ serum leptin + seminal leptin
FSH
Seminal leptin + testicular leptin
Serum leptin + seminal leptin + testicular leptin
FSH+ serum leptin
Testicular leptin
Serum leptin + testicular leptin
Seminal leptin
Serum leptin + seminal leptin
Serum leptin
AUC: area under curve.
CI: conﬁdence interval.
S.E.: standard error of mean.then testicular leptin with 0.809 AUC value, then combination
of serum leptin and testicular leptin with 0.781 AUC value,
then testicular leptin with 0.773 AUC value, then combination
of serum leptin and seminal leptin with 0.759 AUC value and
then ﬁnally serum leptin with 0.605 AUC value.Discussion
In this study we evaluated the leptin levels in serum, seminal
plasma and testicular tissue homogenate and their relation-
ships to spermatogenesis, and evaluated the predictive value
of leptin hormone concentrations in serum and seminal plasma
as markers for the existence of sperm within the testicular tis-
sue in NOA cases compared to control.
To the author’s knowledge this study was the ﬁrst to deter-
mine the level of leptin quantitatively in the testicular tissue.
Moreover, for the ﬁrst time the best threshold concentration
for testicular leptin for discrimination between positive and
negative TESE in NOA men was determined.
Sperm retrieval became the solution for paternity in NOA
men. A previous study has reported that sperm retrieval
chance for each biopsy is 20–50% in these patients (von
Eckardstein et al., 1999). In our study, the chance of sperm
retrieval for NOA men was 27.5% (11 out of 40 patients).eminal leptin, and testicular leptin levels for non-obstructive
AUC S.E. 95% CI
0.909 0.0456 0.775–0.977
0.897 0.0500 0.759–0.970
0.893 0.0583 0.755–0.969
0.893 0.0531 0.755–0.969
0.887 0.0511 0.747–0.965
0.881 0.0540 0.739–0.962
0.828 0.0685 0.675–0.928
0.824 0.0665 0.672–0.926
0.824 0.0674 0.672–0.926
0.821 0.0674 0.668–0.924
0.809 0.0799 0.654–0.916
0.781 0.0797 0.622–0.896
0.773 0.0752 0.613–0.890
0.759 0.0793 0.597–0.880
0.605 0.110 0.438–0.756
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sive markers; FSH, Inh-B and AMH concentrations, to predict
the presence of the spermatozoa in the testicular tissues
(Isikoglu et al., 2006; Tunc et al., 2006; Nistal et al., 2007;
Goulis et al., 2009), while few studies have pointed the use
of leptin for this purpose (Ma et al., 2010; Gao et al., 2011).
The results of the present study have shown that serum lep-
tin concentrations were comparable among all studied groups;
NOR, OA, NOA (+) and NOA () groups. This ﬁnding is
compatible with Zorn et al. who found no signiﬁcant difference
in serum leptin concentrations of non-obstructive azoospermic,
obstructive azoospermic, oligoasthenoteratozoospermic and
normozoospermic men (Zorn et al., 2007), and with Chen
et al. who reported no signiﬁcant difference in serum leptin con-
centrations between varicocele-related (low spermatogenic)
patients and the control group (Chen et al., 2009). On the other
hand, Steinman and his collogues have reported higher serum
leptin concentration in azoospermic men than in normozoo-
spermic men (Steinman et al., 2001), stating that serum leptin
has a direct effect on testis function, speciﬁcally on spermato-
genesis. However, they have shown no signiﬁcant correlation
between serum leptin and testosterone concentrations. They
also have shown no correlation between serum leptin concen-
tration and LH, FSH and prolactin concentrations which is
in agreement with the present results.
Zorn et al. have reported that there is a link between serum
leptin and testicular function independent of FSH and LH,
and they attributed serum leptin direct action on testis to tes-
tosterone and sex hormone binding globulin (SHBG) through
a regulation of Leydig cell function, since they have shown a
signiﬁcant inversely proportional relationship between serum
levels of leptin and total testosterone and SHBG (Zorn
et al., 2007).
Although the present study and that of Zorn et al. (2007)
have reached the same conclusion as Steinman et al. (2001)
who reported that leptin affects testes function and that there
is no correlation between serum leptin and LH and FSH, the
present study and that of Zorn et al. have reported that serum
leptin affects steroidogenesis through a regulation of Leydig
cell function while Steinman et al. reported that serum leptin
affects spermatogenesis.
In the present study, a negative correlation between serum
leptin and total testosterone concentrations was found, this isFig. 1 Receiver operating curves for FSH, serum leptin, seminal
leptin and testicular leptin concentrations for discriminating
successful and failed testicular sperm extraction in non-obstructive
azoospermic patients.in agreement with many authors (Luukkaa et al., 1998; Tena-
Sempere et al., 1999; Hanafy et al., 2007; Zorn et al., 2007;
Jahan et al., 2011). It is also in agreement with others who
reported that serum leptin affects the testes directly through
steroidogenesis (Tena-Sempere et al., 2001; Tena-Sempere
and Barreiro, 2002) and with the review which has reported
that leptin negatively regulates steroidogenesis through direct
actions on Leydig cells (Phillips and Tanphaichitr, 2010).
This negative correlation between serum leptin and total
testosterone may explain the decreased serum testosterone
level observed in obese males in some studies (Zumoff et al.,
1990; Vettor et al., 1997; Isidori et al., 1999; Aggerholm
et al., 2008). Some studies have shown a negative correlation
between BMI and serum testosterone concentration (Fejes
et al., 2006; Aggerholm et al., 2008), which was not the case
with the present study, possibly due to the exclusion of the
obese men.
From the results of the present study no correlation was
observed between neither serum and seminal leptin nor serum
and testicular leptin, which might be due to the testis–blood-
barrier that prevents many large molecules from passing from
the interstitial tissue and the basal compartment of the tubule
to the adluminal compartment of the tubule and the lumen.
Contrarily, some studies have shown a positive correlation
between serum leptin and seminal leptin concentrations
(Banks et al., 1999; von Sobbe et al., 2003; Ando and
Aquila, 2005; Ishikawa et al., 2007) and some of them sug-
gested that leptin is not actively transported but rather leaks
through the testis–blood-barrier (Banks et al., 1999; von
Sobbe et al., 2003).
Previously, it has been shown that leptin exists in the sem-
inal plasma (Camina et al., 2002; Glander et al., 2002; Jope
et al., 2003) and in the seminiferous tubules (Glander et al.,
2002). Also a soluble leptin receptor in the seminal plasma
and a leptin receptor isoform in the ejaculated spermatozoa
have been detected which conﬁrms a role for leptin action in
the male genital tract (Jope et al., 2003). Aquila et al. (2005)
have reported that the origin of seminal plasma leptin is not
exactly deﬁned but concluded that seminal leptin is secreted
by the ejaculated spermatozoa itself, whereas other studies
have attributed the presence of leptin in the seminal plasma
to the leakage of leptin through the testis–blood-barrier
(Banks et al., 1999; von Sobbe et al., 2003). The present study
found detectable levels for leptin in the seminal plasma of
azoospermic and normozoospermic men which afﬁrm that lep-
tin of seminal plasma may be secreted by the whole genital
tract and/or by the testicular tissue itself.
The present study results showed a detectable leptin level in
the testicular homogenate of azoospermic men and also
showed a signiﬁcant direct proportional relationship between
testicular and seminal leptin but not between testicular and
serum leptin, which may indicate that leptin in seminal plasma
is synthesized and secreted by the testicular tissue itself. Detec-
tion of leptin in testicular tissue as found in our study is in con-
tradiction to the previous opinion of Camina et al. who have
stated that testicular tissues are not the source of seminal leptin
but the most likely sources of seminal leptin are either seminal
vesicles or prostate tissue (Camina et al., 2002).
Our results have shown that the azoospermic groups; OA,
NOA (+) and NOA () groups, have higher leptin levels in
the seminal plasma compared with that of the NOR group,
which is in agreement with results of Gao et al. (2011) who
170 M.M.S. Ellithy et al.have shown a signiﬁcant increase in the seminal leptin levels of
OA and NOA groups.
In the study of Gao et al. (2011), the authors have reported
an increase in the seminal leptin concentration of NOA men
compared with that of OA men (Gao et al., 2011). Thus they
investigated the role of serum and seminal leptin as a marker
for obstruction, but did not address the usage of leptin to pre-
dict the existence of sperm in the testicular tissues of NOA
men. This is what is being addressed by this research.
The present study showed that seminal leptin concentra-
tions of OA and NOA (+) men were comparable while
NOA () patients showed higher seminal leptin concentrations
than those of OA and NOA (+), which indicate that seminal
leptin can be used as a marker for spermatogenesis, but not as
a marker for obstruction.
The current study is in agreementwithMaet al. who reported
that FSH is a gooddiscriminativemarker betweenNOA () and
NOA (+) men and also in agreement with them in their conclu-
sion that the combined use of seminal leptin andFSH can signif-
icantly improve theprediction accuracy.This is conﬁrmedby the
ROCcurve of the present study,where itwas shown that the area
under the curve (AUC) of seminal leptin for discrimination
between NOA () and NOA (+) men was 0.773 with P-value
(0.0003). And irrespective of its lower AUC value than that of
FSH (AUC: 0.773 versus 0.828), the logistic regression conﬁrms
that the combined use of both gave AUC value higher than that
of FSH alone; 0.887 versus 0.828, which could signiﬁcantly
improve the prediction accuracy for sperm recovery.
The results of the present study also showed that the testic-
ular leptin concentrations in OA and NOA (+) men were
comparable and both being lower than NOA () men, which
may indicate that there is a link between testicular leptin and
spermatogenesis. This is in agreement with Ishikawa and his
co-workers who have worked on OA, Sertoli cell-only syn-
drome and oligozoospermic patients with varicocele, in com-
parison with ﬁve fertile men, and have observed over-
expression of leptin and leptin receptors in hypospermatoge-
netic testes (Ishikawa et al., 2007). This indication served to
favor the spermatogenic deﬁciency as the source and cause
of elevated seminal leptin rather than pathology of the acces-
sory sex glands; seminal vesicles and prostate.
In the current study, although testicular leptin especially in
combination with FSH had a high predictive value, it is not
clinically applicable considering its invasive nature for an
investigation. Therefore seminal leptin with or without FSH
is the proposed preoperative marker for spermatogenesis.
Prospective researches are needed to answer the question of
whether seminal leptin can be used as a predictive marker for
sperm retrieval in obese cases or not.
In conclusion it can be proposed that the increase in testicu-
lar leptin concentration negatively affects spermatogenesis, but
more future researches should be done to reach the mechanism
of this action. Also, determining the concentration of leptin in
the seminal plasma of NOA patients can be used as a good
assistant marker to predict the success or failure of the sperm
retrieval in NOA men especially in combination with FSH.
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